capitalism (@capitalism) 's Twitter Profile
capitalism

@capitalism

ID: 19874381

calendar_today01-02-2009 20:17:21

41 Tweet

571 Followers

36 Following

capitalism (@capitalism) 's Twitter Profile Photo

Fix the broken American health care system in one shot - Medicare for All! Very simple - just follow Spain's footsteps. Spain nationalizes private hospitals to combat coronavirus outbreak nydailynews.com/coronavirus/ny…

capitalism (@capitalism) 's Twitter Profile Photo

It's morally repulsive how large corporations are exploiting this crisis. Workers will suffer | Robert Reich theguardian.com/commentisfree/…

capitalism (@capitalism) 's Twitter Profile Photo

Economics and Finance Professors from Major Universities Write to Congress : "Bail Out People Before Large Corporations" - go.shr.lc/2Ud60c6 via @shareaholic

capitalism (@capitalism) 's Twitter Profile Photo

Capitalism - The Biggest Turkey of All! //www.ineteconomics.org/perspectives/blog/the-gospel-of-capitalism-is-the-biggest-turkey-of-all #inet

capitalism (@capitalism) 's Twitter Profile Photo

Ivermectin is effective for COVID-19. Early treatment - 85% improvement, p = 0.00019. All studies - 77% improvement, p < 0.0001. 1 in 537 million probability results of the 29 studies are from an ineffective treatment (p = 1.9e-09). ivmmeta.com via Covid Analysis

capitalism (@capitalism) 's Twitter Profile Photo

COVID-19 Vaccination Train Wreck. 1. That doses are being received and not distributed is inexcusable. 2. That doses are being denied, based on over-rigid or contrived local criteria, is inexcusable. hcrenewal.blogspot.com/2021/01/whoops…

capitalism (@capitalism) 's Twitter Profile Photo

" Those that fell under the spell of illusions about free, competitive, and self-regulating markets and under the dominating power of finance. " foreignpolicy.com/2021/01/15/for…

capitalism (@capitalism) 's Twitter Profile Photo

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial medrxiv.org/content/10.110…